Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07451665 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis

Study acronym: VIVA-TAK
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a prospective, open-label, controlled, multiple centers, randonmized clinical trial. It compares the clinical efficacy and safety of vunakizumab ivarmacitinib and glucocorticoids in the treatment of active Takayasu's arteritis.
Trial Details
NCT Number NCT07451665
Lead Sponsor Chinese SLE Treatment And Research Group
Conditions
(from sponsor)		 Takayasu Arteritis (TAK)
Related terms Takayasu Arteritis
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov